Filed: 5/15/2023ACC: 0001104659-23-060801
📋 What this filing means
NORTHPOND VENTURES, LLC filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $174.98M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$174.98M
Total AUM (reported)
24.68M
Total Shares
Allocation by class
COM$174.98M100.0%
Portfolio Concentration
Top 3$166.12M94.9%
4–10$8.87M5.1%
Top 3 weight
94.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 24.68M
Sole
Full voting authority
24.68M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
DICE THERAPEUTICS INC
SOLEShares3.29M
TypeSH
Market value$94.34M
53.91%
Sole
3.29M
Shared
0.00
None
0.00
VIGIL NEUROSCIENCE INC
SOLEShares4.21M
TypeSH
Market value$41.26M
23.58%
Sole
4.21M
Shared
0.00
None
0.00
TELESIS BIO INC
SOLEShares9.84M
TypeSH
Market value$30.52M
17.44%
Sole
9.84M
Shared
0.00
None
0.00
PHENOMEX INC
SOLEShares5.39M
TypeSH
Market value$6.25M
3.57%
Sole
5.39M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares1.94M
TypeSH
Market value$2.61M
1.49%
Sole
1.94M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DICE THERAPEUTICS INCSOLE | COM | 3.29M | SH | $94.34M 53.91% | 3.29M | 0.00 | 0.00 |
VIGIL NEUROSCIENCE INCSOLE | COM | 4.21M | SH | $41.26M 23.58% | 4.21M | 0.00 | 0.00 |
TELESIS BIO INCSOLE | COM | 9.84M | SH | $30.52M 17.44% | 9.84M | 0.00 | 0.00 |
PHENOMEX INCSOLE | COM | 5.39M | SH | $6.25M 3.57% | 5.39M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 1.94M | SH | $2.61M 1.49% | 1.94M | 0.00 | 0.00 |